StonvexLoading…
StonvexStonvexStonvexCore line items from EZPW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $1.27B | $1.16B | $1.05B | $886.23M |
Operating Income | $149.17M | $112.53M | $92.15M | $74.92M |
Net Income | $109.61M | $83.09M | $38.46M | $50.16M |
EPS (Diluted) | $1.42 | $1.10 | $0.53 | $0.70 |
Total Assets | $1.95B | $1.49B | $1.47B | $1.35B |
Total Liabilities | $925.72M | $688.67M | $721.94M | $655.65M |
Cash & Equivalents | $469.52M | $170.51M | $220.59M | $206.03M |
Free Cash Flow OCF − CapEx | $110.42M | $77.84M | $61.39M | $34.64M |
Shares Outstanding | 83.38M | 84.45M | 80.86M | 82.40M |